TMCX+, 2450 Holcombe Boulevard
About Vyripharm BiopharmaceuticalsProvider of drug development services for debilitating diseases. Vyripharm Biopharma develops drugs to target cancer, PTSD, drug addiction and metabolic diseases and aims in improving clinical management through diagnosis and treatment with botanicals, synthetic pharmaceuticals and drug delivery systems.
Co-Founder & President, Research & Development: Elias Jackson Ph.D Co-Founder & Vice President, Research & Development: David Yang Board Member & Executive: Jerry Bryant Jr.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.